<?xml version='1.0' encoding='UTF-8'?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://cellandgene.expert/podcast/eu-post-marketing-requirements-for-cell-and-gene-therapy-studies</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/EU_Post-Marketing_Requirements_for_Cell_and_Gene_Therapy_Studies_Title_Card_d01.jpg</image:loc><image:caption>EUPostMarketingRequirementsforCellandGeneTherapyStudiesTitleCardd01</image:caption><image:title>EUPostMarketingRequirementsforCellandGeneTherapyStudiesTitleCardd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/reasons-for-setting-up-natural-history-studies-their-challenges</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/Veristat-ART_Season_02_podcast_07_Reasons-for-Setting-Up-Natural-History-Studies_Their-Challenges-PROMO_d01.jpg</image:loc><image:caption>VeristatARTSeason02podcast07ReasonsforSettingUpNaturalHistoryStudiesTheirChallengesPROMOd01</image:caption><image:title>VeristatARTSeason02podcast07ReasonsforSettingUpNaturalHistoryStudiesTheirChallengesPROMOd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/the-current-landscape-of-cell-and-gene-therapies</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/Veristat-ART_Season_02_Podcast_The%20current%20landscape%20of%20cell%20and%20gene%20therapies%20and%20where%20headed_PROMO_d01.jpg</image:loc><image:caption>VeristatARTSeason02PodcastThecurrentlandscapeofcellandgenetherapiesandwhereheadedPROMOd01</image:caption><image:title>VeristatARTSeason02PodcastThecurrentlandscapeofcellandgenetherapiesandwhereheadedPROMOd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2022-12-30</lastmod></url><url><loc>https://cellandgene.expert</loc><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Common%20Pitfalls%20Marketing%20Application.png</image:loc><image:caption>HubDBCardImagePodcastCSCommonPitfallsMarketingApplication</image:caption><image:title>HubDBCardImagePodcastCSCommonPitfallsMarketingApplication</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Autologous%20Therapies.png</image:loc><image:caption>HubDBCardImagePodcastCSAutologousTherapies</image:caption><image:title>HubDBCardImagePodcastCSAutologousTherapies</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Common%20Pitfalls%20Cell.png</image:loc><image:caption>HubDBCardImagePodcastCSCommonPitfallsCell</image:caption><image:title>HubDBCardImagePodcastCSCommonPitfallsCell</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Common%20Pitfalls%20Gene.png</image:loc><image:caption>HubDBCardImagePodcastCSCommonPitfallsGene</image:caption><image:title>HubDBCardImagePodcastCSCommonPitfallsGene</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Use%20of%20Pro.png</image:loc><image:caption>HubDBCardImagePodcastCSUseofPro</image:caption><image:title>HubDBCardImagePodcastCSUseofPro</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/Veristat-ART_Season_02_Podcast_The%20current%20landscape%20of%20cell%20and%20gene%20therapies%20and%20where%20headed_PROMO_d01.jpg</image:loc><image:caption>VeristatARTSeason02PodcastThecurrentlandscapeofcellandgenetherapiesandwhereheadedPROMOd01</image:caption><image:title>VeristatARTSeason02PodcastThecurrentlandscapeofcellandgenetherapiesandwhereheadedPROMOd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Social%20Media_Assets_ART%20Meta.png</image:loc><image:caption>SocialMediaAssetsARTMeta</image:caption><image:title>SocialMediaAssetsARTMeta</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/Veristat-ART_Season_02_podcast_07_Reasons-for-Setting-Up-Natural-History-Studies_Their-Challenges-PROMO_d01.jpg</image:loc><image:caption>VeristatARTSeason02podcast07ReasonsforSettingUpNaturalHistoryStudiesTheirChallengesPROMOd01</image:caption><image:title>VeristatARTSeason02podcast07ReasonsforSettingUpNaturalHistoryStudiesTheirChallengesPROMOd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Planning%20Way%20Forward.png</image:loc><image:caption>HubDBCardImagePodcastCSPlanningWayForward</image:caption><image:title>HubDBCardImagePodcastCSPlanningWayForward</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/Veristat-ART_Season_02_podcast_03-podcast_03-Opportunities_for_Virtual_and_Central_Site_Models_in_Cell_and_Gene_Therapy_Trials-THUMBNAIL_d01.jpg</image:loc><image:caption>VeristatARTSeason02podcast03podcast03OpportunitiesforVirtualandCentralSiteModelsinCellandGeneTherapyTrialsTHUMBNAILd01</image:caption><image:title>VeristatARTSeason02podcast03podcast03OpportunitiesforVirtualandCentralSiteModelsinCellandGeneTherapyTrialsTHUMBNAILd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Selecting%20Endpoints.png</image:loc><image:caption>HubDBCardImagePodcastCSSelectingEndpoints</image:caption><image:title>HubDBCardImagePodcastCSSelectingEndpoints</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_Title%20Card_Into%20to%20Natural%20History%20Studies.png</image:loc><image:caption>HubDBCardImagePodcastTitleCardIntotoNaturalHistoryStudies</image:caption><image:title>HubDBCardImagePodcastTitleCardIntotoNaturalHistoryStudies</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Long%20Term%20Gene%20Therapy.png</image:loc><image:caption>HubDBCardImagePodcastCSLongTermGeneTherapy</image:caption><image:title>HubDBCardImagePodcastCSLongTermGeneTherapy</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_EU%20Post%20Marketing.png</image:loc><image:caption>HubDBCardImagePodcastCSEUPostMarketing</image:caption><image:title>HubDBCardImagePodcastCSEUPostMarketing</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Real%20World%20Considerations.png</image:loc><image:caption>HubDBCardImagePodcastCSRealWorldConsiderations</image:caption><image:title>HubDBCardImagePodcastCSRealWorldConsiderations</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/HubDB_Card%20Image_Podcast_CS_Logistics%20Scale%20Up.png</image:loc><image:caption>HubDBCardImagePodcastCSLogisticsScaleUp</image:caption><image:title>HubDBCardImagePodcastCSLogisticsScaleUp</image:title></image:image><lastmod>2024-07-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/introduction-to-natural-history-studies</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_S2E2_thumbnail-2.jpeg</image:loc><image:caption>ARTS2E2thumbnail2</image:caption><image:title>ARTS2E2thumbnail2</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/An_Introduction_to_Natural_History_Studies_Title_Card_d01.jpg</image:loc><image:caption>AnIntroductiontoNaturalHistoryStudiesTitleCardd01</image:caption><image:title>AnIntroductiontoNaturalHistoryStudiesTitleCardd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/selecting-endpoints-for-an-early-phase-cell-or-gene-study</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/ART-hero-image-1920-R.png</image:loc><image:caption>ARTheroimage1920R</image:caption><image:title>ARTheroimage1920R</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/Veristat-ART_Podcast_05-Robin%20Bliss_Selecting_Endpoints_for_an_Early_Phase_Cell_Gene_Study-PROMO_d01.jpg</image:loc><image:caption>VeristatARTPodcast05RobinBlissSelectingEndpointsforanEarlyPhaseCellGeneStudyPROMOd01</image:caption><image:title>VeristatARTPodcast05RobinBlissSelectingEndpointsforanEarlyPhaseCellGeneStudyPROMOd01</image:title></image:image><lastmod>2021-12-30</lastmod></url><url><loc>https://cellandgene.expert/podcast/use-of-pro-in-cell-and-gene-therapy-studies</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Use_of_PRO_in_Cell_and_Gene_Therapy_Studies_Title_Card_d01.jpg</image:loc><image:caption>UseofPROinCellandGeneTherapyStudiesTitleCardd01</image:caption><image:title>UseofPROinCellandGeneTherapyStudiesTitleCardd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/pitfalls-to-avoid-when-planning-a-marketing-application-for-cell-and-gene-therapies</loc><image:image><image:loc>https://info.veristat.com/hubfs/Common_Pitfalls_to_Avoid_When_Planning_a_Marketing_Application_Title_Card_d01.jpg</image:loc><image:caption>CommonPitfallstoAvoidWhenPlanningaMarketingApplicationTitleCardd01</image:caption><image:title>CommonPitfallstoAvoidWhenPlanningaMarketingApplicationTitleCardd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/common-pitfalls-in-gene-therapy-studies</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Common_Pitfalls_in_Gene_Therapy_Studies_Title_Card_d01.jpg</image:loc><image:caption>CommonPitfallsinGeneTherapyStudiesTitleCardd01</image:caption><image:title>CommonPitfallsinGeneTherapyStudiesTitleCardd01</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/common-pitfalls-in-cell-therapy-studies</loc><image:image><image:loc>https://info.veristat.com/hubfs/Common_Pitfalls_in_Cell_Therapy_Studies_Title_Card_d01.jpg</image:loc><image:caption>CommonPitfallsinCellTherapyStudiesTitleCardd01</image:caption><image:title>CommonPitfallsinCellTherapyStudiesTitleCardd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/are-allogeneic-therapies-the-future</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Are_Autologous_Therapies_Here_to_Stay_Title_Card_d01.jpg</image:loc><image:caption>AreAutologousTherapiesHeretoStayTitleCardd01</image:caption><image:title>AreAutologousTherapiesHeretoStayTitleCardd01</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/planning-the-way-forward-in-neurodegenerative-disease-studies</loc><image:image><image:loc>https://info.veristat.com/hubfs/Planning_the_Way_Forward_in_Neurodegenerative%20Disease_Studies_Title_Card_d01.jpg</image:loc><image:caption>PlanningtheWayForwardinNeurodegenerativeDiseaseStudiesTitleCardd01</image:caption><image:title>PlanningtheWayForwardinNeurodegenerativeDiseaseStudiesTitleCardd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/opportunities-for-virtual-and-central-site-models-in-cell-and-gene-therapy-trials</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/custom-video-thumbnails/Veristat-ART_Season_02_podcast_03-podcast_03-Opportunities_for_Virtual_and_Central_Site_Models_in_Cell_and_Gene_Therapy_Trials-THUMBNAIL_d01.jpg</image:loc><image:caption>VeristatARTSeason02podcast03podcast03OpportunitiesforVirtualandCentralSiteModelsinCellandGeneTherapyTrialsTHUMBNAILd01</image:caption><image:title>VeristatARTSeason02podcast03podcast03OpportunitiesforVirtualandCentralSiteModelsinCellandGeneTherapyTrialsTHUMBNAILd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/real-world-considerations-when-administering-advanced-therapy-products</loc><image:image><image:loc>https://info.veristat.com/hubfs/Real-World_Considerations_When_Administering_Advanced%20Therapy_Products_Title_Card_d01.jpg</image:loc><image:caption>RealWorldConsiderationsWhenAdministeringAdvancedTherapyProductsTitleCardd01</image:caption><image:title>RealWorldConsiderationsWhenAdministeringAdvancedTherapyProductsTitleCardd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/long-term-follow-up-studies-in-gene-therapy</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Long-Term_Follow-Up_Studies_in_Gene_Therapy_Title_Card_d01.jpg</image:loc><image:caption>LongTermFollowUpStudiesinGeneTherapyTitleCardd01</image:caption><image:title>LongTermFollowUpStudiesinGeneTherapyTitleCardd01</image:title></image:image><lastmod>2023-01-03</lastmod></url><url><loc>https://cellandgene.expert/podcast/the-logistics-of-a-clinical-study-scale-up</loc><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART-hero-image-1920.jpg</image:loc><image:caption>ARTheroimage1920</image:caption><image:title>ARTheroimage1920</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/The_Logistics_of_a_Clinical_Study_%20Scale-Up_Title_Card_d01.jpg</image:loc><image:caption>TheLogisticsofaClinicalStudyScaleUpTitleCardd01</image:caption><image:title>TheLogisticsofaClinicalStudyScaleUpTitleCardd01</image:title></image:image><image:image><image:loc>https://info.veristat.com/hubfs/Podcast/ART_logo_reversed_horizontal_stacked.png</image:loc><image:caption>ARTlogoreversedhorizontalstacked</image:caption><image:title>ARTlogoreversedhorizontalstacked</image:title></image:image><lastmod>2023-01-03</lastmod></url></urlset>